Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Eastern Hepatobiliary Surgery Hospital

Clinical trials sponsored by Eastern Hepatobiliary Surgery Hospital, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Tumor 'avatars' could guide liver cancer treatment in new trial Results expected Oct 2026 (estimated)
  • Mini-Tumors in a dish could pick the perfect cancer drug Results expected Oct 2026 (estimated)
  • Lab-Grown tumor clones could pick best drugs for liver cancer patients Results expected Oct 2026 (estimated)
  • Can a Triple-Drug combo shrink inoperable bile duct tumors? Results expected Dec 2026 (estimated)
  • New ultrasound technique could reveal hidden blood vessels in liver tumors Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 3 Not yet recruiting 7 Not yet finished but already full! 1 Completed 1
Sort by
  • Can a Triple-Drug combo shrink inoperable bile duct tumors?

    Disease control Ongoing

    This phase II trial is testing whether a combination of three treatments—QL1706 (an immunotherapy), lenvatinib (a targeted therapy), and GEMOX (two chemotherapy drugs)—can help people with bile duct or gallbladder cancer that cannot be removed by surgery. The study will enroll ab…

    Phase 2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control

    Last updated Aug 26, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space